Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Relationship Between Therapeutic Changes in Blood Pressure and Outcomes in Acute Stroke. A Metaregression
Hypertension, 08/06/09
Geeganage CM et al. – Randomized, controlled trials of interventions that would be expected, on pharmacological grounds, to alter BP in patients within 1 week of the onset of acute ischemic or hemorrhagic stroke were sought using electronic searches. The relationship between the differences in on–treatment BP and odds ratios for outcomes was assessed using meta–regression. Although large falls or increases in BP are associated with a worse outcome, modest reductions may reduce death and combine death or dependency, although the CIs are wide and compatible with an overall benefit or hazard.
Philip M.W. Bath, 08/07/09
| We have performed a meta-regression analysis of 37 randomized controlled trials of interventions that would be expected, on pharmacological grounds, to alter BP in 9008 patients with acute stroke.1 The results revealed a U-shaped relationship between blood pressure changes and outcome; with the lowest risk of death or combined death or dependency at the end of follow-up in patients with blood pressure reductions ranged from 8-15 mmHg. Although large falls or increase in blood pressure were associated with a higher risk of poor outcomes, a modest reductions may reduce death and combined death or dependency, although confidence intervals were wide and compatible with an overall benefit or hazard. The results justify the testing of whether lowering BP is beneficial in improving functional outcome, as is being done in several large ongoing randomized controlled trials. Chamila M Geeganage and Philip MW Bath Stroke Trials Unit, University of Nottingham, Nottingham NG5 1PB, UK Correspondence to Professor Philip MW Bath, Stroke Trials Unit, University of Nottingham, Nottingham NG5 1PB, UK Email: philip.bath@nottingham.ac.uk References 1.Geeganage CM, Bath PM. Relationship between therapeutic changes in blood pressure and outcomes in acute stroke. A metaregression. Hypertension. 2009 |
Related Articles
Differences Between Ischemic Stroke Subtypes in Vascular Outcomes Support a Distinct Lacunar Ischemic Stroke Arteriopathy. A Prospective, Hospital-Based Study
Stroke, 11/09/09
Relevance Score: 93%
Oral anticoagulant therapy safely prevented stroke in older patients with atrial fibrillation
Evidence-Based Medicine, 10/26/09
Relevance Score: 93%
Ischemic stroke and hyperhomocysteinemia: truth or myth
Acta Neurologica Belgica, 10/21/09
Relevance Score: 93%
Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality
Preventive Medicine, 10/16/09
Relevance Score: 93%
Prevention and management of stroke in very elderly patients
The Lancet Neurology, 10/15/09
Relevance Score: 93%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Discrepancies between Office and Ambulatory Blood Pressure: Clinical Implications
American Journal of Medicine, 12/10/09
Role of ambulatory and home blood pressure recording in clinical practice
Current Cardiology Reports, 12/10/09
Hypertension and hemostatic/fibrinolytic balance disorders
Clinical and Investigative Medicine, 12/10/09
Today in Vascular...keeping you current
Receive free subspecialty "5-minute updates" via email
Chronic Mineral Dysregulation Promotes Vascular Smooth Muscle Cell Adaptation and Extracellular Matrix Calcification
Journal of the American Society of Nephrology, 12/10/09
Outcomes Among Hypertensive Patients With Concomitant Peripheral and Coronary Artery Disease. Findings From the INternational VErapamil-SR/Trandolapril STudy
Hypertension, 12/09/09
RGS4 Controls Renal Blood Flow and Inhibits Cyclosporine-Mediated Nephrotoxicity
American Journal of Transplantation, 12/08/09
Article Search
Sponsor


See Latest Articles


